Press Releases

GlobeNewswire, Inc.

-- ANTLER phase 1 data presented at EHA 2026 reinforce vispa-cel safety, efficacy, and durability are on par with approved autologous CAR-T cell therapies and that vispa-cel has the potential to overcome access barriers for patients with 2L LBCL...

GlobeNewswire, Inc.

Exton, PA, Aug. 13, 2026 (GLOBE NEWSWIRE) -- The treatment paradigm for inflammatory bowel disease (IBD) may be shifting faster in physician preference than in clinical practice.

EIN Presswire

Manchester's economic momentum draws private equity capital as AND Capital partners with developer Forshaw to back regeneration across the North MANCHESTER, UNITED KINGDOM, August 13, 2026 /⁨EINPresswire.com⁩/ -- AND Capital Ventures ("AND...

GlobeNewswire, Inc.

Trust Stamp Malta Limited, has been selected as a direct participant in the Important Project of Common European Interest on Advanced Semiconductor Technologies (IPCEI AST), with the support of Malta Enterprise.

EIN Presswire

İSTANBUL, İSTANBUL, TURKEY, August 13, 2026 /⁨EINPresswire.com⁩/ -- Inaugural GITEX Ai Türkiye 2026 unites global tech ecosystem at Istanbul Expo Centre on 9–10 September as the world’s largest tech and AI event network spotlights Eurasia’s...

EIN Presswire

İSTANBUL, İSTANBUL, TURKEY, August 13, 2026 /⁨EINPresswire.com⁩/ -- Inaugural GITEX Ai Türkiye 2026 unites global tech ecosystem at Istanbul Expo Centre on 9–10 September as the world’s largest tech and AI event network spotlights Eurasia’s...

EIN Presswire

İSTANBUL, İSTANBUL, TURKEY, August 13, 2026 /⁨EINPresswire.com⁩/ -- Inaugural GITEX Ai Türkiye 2026 unites global tech ecosystem at Istanbul Expo Centre on 9–10 September as the world’s largest tech and AI event network spotlights Eurasia’s...

EIN Presswire

Jedox partners with Polestar Analytics, pairing its leading EPM platform with Polestar's AI planning and data engineering expertise.

GlobeNewswire, Inc.

Ramat Gan, Israel, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Odysight.ai Inc. (NASDAQ/TASE: ODYS), a leader in AI-powered visual sensing and predictive maintenance (PdM) solutions for the aerospace, defense, and industrial markets, today announces its...

GlobeNewswire, Inc.

Austin, TX, USA, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Blood Bank Information System Market Size, Trends and Insights By Type (Blood Donor Management Module, Blood Bank Transfusion...

GlobeNewswire, Inc.

FORT LAUDERDALE, Fla., Aug. 13, 2026 (GLOBE NEWSWIRE) -- via IBN – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery...

GlobeNewswire, Inc.

Site activation and screening for the Phase 3 RESTORE study is expected to begin in September 2026, with the first participant anticipated to be dosed shortly thereafter.

GlobeNewswire, Inc.

– Q2 2026 product revenue of €315 million (+105% Y/Y), comprising €252 million for YORVIPATH®, €55 million for SKYTROFA®, and €8 million for YUVIWEL® – Through July 31, more than 220 unique YUVIWEL patient enrollments in the U.S. – Substantial...

GlobeNewswire, Inc.

Reports $1.8 million revenue for quarter ended June 30, 2026; reaffirms revenue guidance of $8 million for CY2026 and $16-$18 million for CY2027 PMA supplement for second-generation LungFit PH system under FDA review; approval expected in 2H...

GlobeNewswire, Inc.

Registrational RESET-Myositis® clinical data on track to be reported in mid-2027 to support 2H27 BLA submission for rese-cel Juvenile myositis Phase 1/2 data expected to be submitted with BLA to support potential FDA Priority Review Voucher...

GlobeNewswire, Inc.

EscharEx® Phase III VALUE Trial Advancing; Interim Assessment and Enrollment Completion Expected by End of First Quarter 2027 Master Services Agreement Signed with Vericel Under its BARDA Contract for NexoBrid® Second Quarter Revenue of $3.1...

GlobeNewswire, Inc.

- Obexelimab BLA submission for the treatment of IgG4-RD accepted by FDA; PDUFA target action date of May 27, 2027 - - New study data confirm bioequivalence of obexelimab single-dose prefilled autoinjector pen compared to prefilled syringes - -...

GlobeNewswire, Inc.

Advanced zolucatetide across multiple Wnt/β-catenin-driven diseases, including progress toward planned Phase 3 registrational trial in desmoid tumors Announced strategic research collaboration with Regeneron to develop Antibody-Helicon Conjugates,...

GlobeNewswire, Inc.

NEW YORK, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Lotus Technology Inc. (Nasdaq: LOT) (“Lotus Tech” or the “Company”), a leading global intelligent and luxury mobility provider, today announced that it will report its unaudited financial results for the...

GlobeNewswire, Inc.

First clinical validation of Axiomer™ RNA editing established through NTCP modulation with positive AX-0810 clinical target engagement data; full Phase 1 dataset to be presented at a medical or scientific conference later this year Multiple...